PH12012500557A1 - Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations - Google Patents
Method for producing proanthocyanidin polymer compositions for pharmaceutical formulationsInfo
- Publication number
- PH12012500557A1 PH12012500557A1 PH1/2012/500557A PH12012500557A PH12012500557A1 PH 12012500557 A1 PH12012500557 A1 PH 12012500557A1 PH 12012500557 A PH12012500557 A PH 12012500557A PH 12012500557 A1 PH12012500557 A1 PH 12012500557A1
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical formulations
- polymer compositions
- proanthocyanidin polymer
- producing
- producing proanthocyanidin
- Prior art date
Links
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 title 1
- 229920001991 Proanthocyanidin Polymers 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1962MU2009 | 2009-08-26 | ||
| PCT/IB2010/002060 WO2011024049A2 (en) | 2009-08-26 | 2010-08-24 | Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12012500557A1 true PH12012500557A1 (en) | 2012-10-22 |
Family
ID=43337818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2012/500557A PH12012500557A1 (en) | 2009-08-26 | 2010-08-24 | Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations |
Country Status (4)
| Country | Link |
|---|---|
| EA (1) | EA023814B1 (en) |
| PH (1) | PH12012500557A1 (en) |
| WO (1) | WO2011024049A2 (en) |
| ZA (1) | ZA201202160B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2632550B1 (en) | 2010-10-31 | 2017-05-03 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating hiv-associated diarrhea |
| WO2012101008A1 (en) * | 2011-01-27 | 2012-08-02 | Glenmark Pharmaceuticals Limited | Process for the production of proanthocyanidin polymeric composition |
| CN102210538A (en) * | 2011-05-04 | 2011-10-12 | 惠州市欧野科技有限公司 | Eaglewood powder and latex mixed pillow and manufacturing method thereof |
| RU2014124981A (en) * | 2011-12-22 | 2016-02-10 | Гленмарк Фармасьютикалс Лимитед | NON-ENERGY-LUBRICANT PHARMACEUTICAL COMPOSITION CONTAINING CROPHELEMER |
| US9597298B2 (en) * | 2013-06-07 | 2017-03-21 | Remi Shrivastava | Composition for topical application comprising glycerol and tannins |
| US20170095442A1 (en) * | 2014-05-29 | 2017-04-06 | Jaguar Animal Health, Inc. | Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals |
| US20170119834A1 (en) * | 2014-05-29 | 2017-05-04 | Jaguar Animal Health, Inc. | Methods of Treating Diarrhea in Adult Non-Human Animals |
| CN105294636B (en) * | 2015-11-16 | 2018-11-27 | 大兴安岭林格贝寒带生物科技股份有限公司 | A method of preparing glucosidase procyanidins |
| RU2639291C2 (en) * | 2016-03-29 | 2017-12-20 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Method and composition of producing dry forms of blue anthocyanins |
| US12241877B2 (en) | 2019-04-08 | 2025-03-04 | R.P. Scherer Technologies, Llc | Analytical method |
| US12440529B2 (en) * | 2020-09-22 | 2025-10-14 | Alphyn Biologics, Inc. | Topical Croton lechleri compositions and their use in the treatment of a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder |
| US20220088102A1 (en) * | 2020-09-22 | 2022-03-24 | Alphyn Biologics, Llc | Croton lechleri compositions and their use in the treatment of cystic fibrosis |
| CN117715651A (en) * | 2021-02-25 | 2024-03-15 | 阿尔芬生物制品股份有限公司 | Composition for treating topical skin bacterial skin disorders |
| JP2024508454A (en) * | 2021-02-25 | 2024-02-27 | アルフィン バイオロジックス、エルエルシー | Composition for topical skin bacterial skin disease treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5211944A (en) * | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| EP0935417B1 (en) * | 1996-10-16 | 2009-05-06 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| WO2000047062A2 (en) * | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| CA2657803C (en) * | 2006-05-01 | 2019-01-08 | Napo Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer |
-
2010
- 2010-08-24 PH PH1/2012/500557A patent/PH12012500557A1/en unknown
- 2010-08-24 WO PCT/IB2010/002060 patent/WO2011024049A2/en not_active Ceased
- 2010-08-24 EA EA201290098A patent/EA023814B1/en active IP Right Revival
-
2012
- 2012-03-23 ZA ZA2012/02160A patent/ZA201202160B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011024049A2 (en) | 2011-03-03 |
| WO2011024049A3 (en) | 2011-05-19 |
| EA023814B1 (en) | 2016-07-29 |
| ZA201202160B (en) | 2013-08-28 |
| WO2011024049A9 (en) | 2013-04-25 |
| EA201290098A1 (en) | 2013-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12012500556A1 (en) | Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations | |
| ZA201202160B (en) | Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations | |
| IL211008A0 (en) | Thienopyrimidines for pharmaceutical compositions | |
| GB0814695D0 (en) | Pharmaceutical compositions | |
| SG2014012405A (en) | Pharmaceutical compositions | |
| PL2323623T3 (en) | Pharmaceutical compositions | |
| ZA201107776B (en) | Pharmaceutical composition | |
| IL213545A0 (en) | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | |
| IL213546A0 (en) | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | |
| IL218937A0 (en) | Pharmaceutical compositions comprising rivaroxaban | |
| ZA201304127B (en) | Oral compositions and method for producing thereof | |
| IL206487A0 (en) | Pharmaceutical compositions | |
| EP2393361A4 (en) | Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them | |
| ZA201304126B (en) | Oral compositions and method for producing thereof | |
| IL219018A0 (en) | Pharmaceutical compositions | |
| ZA201304088B (en) | Oral compositions and method for producing thereof | |
| EP2473168A4 (en) | Pharmaceutical formulations for indibulin | |
| GB0800659D0 (en) | Pharmaceutical Compositions | |
| GB0902428D0 (en) | Pharmaceutical methods & compositions | |
| GB0921139D0 (en) | Pharmaceutical methods & compositions | |
| GB0901241D0 (en) | Pharmaceutical compositions | |
| AU2009905147A0 (en) | Pharmaceutical Compositions | |
| HK1174530A (en) | Pharmaceutical compositions | |
| GB0806156D0 (en) | Pharmaceutical compositions | |
| GB0806283D0 (en) | Pharmaceutical compositions |